Has Rasha Waheed, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,495 in general payments to Rasha Waheed, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rasha Waheed, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rasha Waheed, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rasha Waheed, MD

Neurology · Royal Oak, MINPI 1902252471

Payments from drug & device makers

$1,495in general payments, 2019–2025

Across 32 payments — averaging $46.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lundbeck LLC$263
EMD Serono, Inc.$205
Novartis$199
Genentech USA, Inc.$154
Amgen$140
E.r. Squibb & Sons, L.L.C.$125
plus $408 from 10 others

What the payments were for

Food & beverage$1,495100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lundbeck LLC	4	$263
EMD Serono, Inc.	4	$205
Novartis	6	$199
Genentech USA, Inc.	2	$154
Amgen	2	$140
E.r. Squibb & Sons, L.L.C.	1	$125
Sanofi	1	$124
AbbVie	1	$48
Livanova USA, Inc.	2	$48
Vanda Pharmaceuticals Inc.	2	$47
Philips North America LLC	1	$35
Jazz Pharmaceuticals Inc.	2	$33
Otter Pharmaceuticals, LLC	1	$24
Neurelis, Inc.	1	$23
Bristol Myers Squibb	1	$15
Cycle Pharmaceuticals Inc	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,495 in reported general payments places this provider in the 50th percentile of 652 neurology providers in Michigan.

See all neurology providers in Michigan →

Medicare billing

Part B allowed, 2024

$35,496

Medicare patients

Services billed

332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Levetiracetam	26	$1,061
Gabapentin	27	$326
Tramadol Hcl	12	$26

Paid to pharmacies, not to this prescriber.

Other neurology in Royal Oak

Aaron EllenbogenFarmington Hills$14.5M
Martin BelkinFarmington Hills$5.8M
Evanthia BernitsasDetroit$4.8M
Yang Mao DraayerFarmington Hills$4.2M
Mirela CerghetDetroit$3.8M
Peter le WittWest Bloomfield$3.2M
Judith HeidebrinkAnn Arbor$2.2M
Denise LeungAnn Arbor$2M
Rany AburashedOwosso$1.9M
Jeanie CoteOwosso$1.8M

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →